While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

Billion in New Commitments Closed in the Fourth Quarter, Reaching a Record of $48.2 Billion Closed in the 12 Months Ended December 31, 2024 NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Ares ...

Drugmaker pauses HPV Gardasil exports as rival Pfizer gets boost from better than expected Covid vaccine and pill sales ...

Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

MSD Global Health Innovation Fund, a corporate venture capital arm of Merck & Co., Inc., Rahway, NJ, USA, who became an Evaxion shareholder in December 2023, participated in this offering along with ...

Evaxion Biotech (EVAX) announced the pricing of a public offering of an aggregate of 3,997,361 of its American Depositary Shares and warrants ...

Evaxion Biotech (EVAX) shares dropped 25% premarket after pricing a $10.8M public offering to advance its preclinical and clinical pipeline.

The US Food and Drug Administration (FDA) will soon decide on whether to expand the label of MSD’s Welireg (belzutifan) to ...

Despite having been announced over five years ago, we barely know anything about BioShock 4, and have next to nothing that's been officially confirmed. This is a shame given it's one of the most ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Look at recent big pharma asset acquisitions and new biotech company launches, and you might spot a common theme: The drugs at the heart of these deals were originally developed in China.